Translate
Bioatla Inc
About
Bioatla Inc (NASDAQ:BCAB) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 31 2026
BioAtla Announces Share Consolidation
Mar 31 2026
BioAtla Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Mar 2 2026
BioAtla Announces Formal Process to Evaluate Strategic Options to Monetize Assets
Dec 31 2025
BioAtla and GATC Health Announce a $40 Million Special Purpose Vehicle (SPV) Transaction to Advance Ozuriftamab Vedotin (Oz-V) into a Registrational Trial for 2L+ Oropharyngeal Squamous Cell Carcinoma (OPSCC)
Nov 21 2025
BioAtla Enters into Agreements for up to $22.5 Million Flexible Financing
Recent Videos
BioAtla's Bold Moves: Layoffs & Strategic Shifts! #BioAtla #BCAB #Biotech #Layoffs #StrategicShifts
Apr 13, 2026
BioAtla's Delisting Threat: My Take on Their Financials
Feb 10, 2026
My Insight on BioAtla's Super-Voting Share Strategy
Jan 16, 2026
RANGE BREAKOUT : BCAB STOCK ANALYSIS | BIOATLA STOCK
Dec 20, 2025
Financials
Revenue
$2 M
Market Cap
$9.36 M
EPS
-50.50